Skip to content
← Holders

Krensavage Asset Management, LLC

What Krensavage Asset Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1609251 · Filed Nov 17, 2026

Positions
20
Reported value
$265.4K
Opened
3
Closed
1
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$234.7K
    17 positions
  2. Dec 31, 2025$283.1K
    18 positions
  3. Mar 31, 2026$255.7K
    20 positions
  4. Jun 30, 2026$263.2K
    18 positions
  5. Sep 30, 2026$265.4K
    20 positions
SecuritySharesChangeValueOf portfolio
JAZZJazz Pharmaceuticals plc
167.8K±0%$38.9K14.6%
ENTAEnanta Pharmaceuticals Inc
2.9M±0%$37.8K14.2%
UTHRUnited Therapeutics Corp
66.3K−4.3%$35.9K13.5%
BMRNBioMarin Pharmaceutical Inc
524.8K±0%$31.5K11.9%
ABTAbbott Laboratories
200K±0%$19.8K7.4%
EXELExelixis, Inc.
299.4K−19.2%$17.5K6.6%
RAREUltragenyx Pharmaceutical Inc.
1.1M+191.9%$17.1K6.5%
SUPNSupernus, Inc.
350.7K+24.9%$15.1K5.7%
SNYSanofi
333.9K+3.1%$13.8K5.2%
EMBCEmbecta Corp.
1.1M±0%$6.4K2.4%
ARDXArdelyx, Inc.
1.8M+239.6%$6.2K2.3%
BNTXBioNTech SE
59.5K±0%$5.9K2.2%
VNDAVanda Pharmaceuticals Inc.
1.2M±0%$5.8K2.2%
GSKGSK PLC
96.7K±0%$4.7K1.8%
BIIBBiogen Inc.
20K±0%$4.5K1.7%
INMDInMode Ltd.
120.9K±0%$1.7K0.6%
ANIPANI Pharmaceuticals Inc
13KNew$9440.4%
ACADAcadia Pharmaceuticals Inc
40KNew$8060.3%
ZTSZoetis Inc.
10KNew$6980.3%
EOLSEvolus, Inc.
58K−63.3%$4640.2%